Literature DB >> 15936300

Understanding severe hyperbilirubinemia and preventing kernicterus: adjuncts in the interpretation of neonatal serum bilirubin.

Michael Kaplan1, Cathy Hammerman.   

Abstract

The serum total bilirubin concentration at any point in time represents the amount of bilirubin being produced minus that being excreted. Hyperbilirubinemia develops when bilirubin production exceeds the body's capacity to excrete it, primarily by conjugation. When extreme, hyperbilirubinemia may lead to the development of free bilirubin, that form of bilirubin which may cross the blood-brain barrier and enter and damage the basal nuclei of the brain. This rare, though devastating complication, may result in irreversible bilirubin induced brain damage termed kernicterus. In this paper, adjuncts to the interpretation of the serum total bilirubin are discussed, with the purpose of singling out those few neonates in real danger of bilirubin encephalopathy. Interpretation of the serum total bilirubin should be performed in conjunction with factors unique to the particular infant being evaluated. Understanding the mechanisms and dangers of severe neonatal hyperbilirubinemia should facilitate recognition of an emergency situation and optimize the speed with which bilirubin testing is performed and blood for exchange transfusion prepared. Hyperbilirubinemia is a condition of major importance and a source of concern to all involved in the management of the newborn. Its prevention and management should be based on the recently revised American Academy of Pediatric guidelines, with special attention paid to neonates manifesting risk factors for kernicterus. Close cooperation between the clinical laboratory and the medical team managing the newborn is an essential component in the management of a hyperbilirubinemic baby.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15936300     DOI: 10.1016/j.cccn.2005.01.008

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

1.  Photolysis of bilirubin in serum specimens exposed to room lighting.

Authors:  Nadja N Rehak; Stacey A Cecco; Glen L Hortin
Journal:  Clin Chim Acta       Date:  2007-10-02       Impact factor: 3.786

2.  Muscular dystonia and athetosis in six patients with congenital nephrotic syndrome of the Finnish type (NPHS1).

Authors:  Hanne Laakkonen; Tuula Lönnqvist; Johanna Uusimaa; Erik Qvist; Leena Valanne; Matti Nuutinen; Marja Ala-Houhala; Kari Majamaa; Hannu Jalanko; Christer Holmberg
Journal:  Pediatr Nephrol       Date:  2005-12-17       Impact factor: 3.714

3.  Cross-talk between neurons and astrocytes in response to bilirubin: adverse secondary impacts.

Authors:  Ana Sofia Falcão; Rui F M Silva; Ana Rita Vaz; Cátia Gomes; Adelaide Fernandes; Andreia Barateiro; Claudio Tiribelli; Dora Brites
Journal:  Neurotox Res       Date:  2014-07       Impact factor: 3.911

Review 4.  Glucose-6-Phosphate Dehydrogenase Deficiency and the Need for a Novel Treatment to Prevent Kernicterus.

Authors:  Anna D Cunningham; Sunhee Hwang; Daria Mochly-Rosen
Journal:  Clin Perinatol       Date:  2016-02-28       Impact factor: 3.430

Review 5.  Bilirubin Encephalopathy.

Authors:  Shuo Qian; Prateek Kumar; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2022-05-19       Impact factor: 5.081

6.  Comparison of Two Phototherapy Methods (Prophylactic vs Therapeutic) for Management of Hyperbilirubinemia in Very Low Birth Weight Newborns.

Authors:  Ramin Iranpour; Majid Mohammadizadeh; Seyedeh-Sarah Nazem-Sadati
Journal:  Iran J Pediatr       Date:  2011-12       Impact factor: 0.364

7.  The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation.

Authors:  Dora Brites
Journal:  Front Pharmacol       Date:  2012-05-29       Impact factor: 5.810

8.  Ex vivo (1)H nuclear magnetic resonance spectroscopy reveals systematic alterations in cerebral metabolites as the key pathogenetic mechanism of bilirubin encephalopathy.

Authors:  Wenyi Hu; Xiaojie Cheng; Xinjian Ye; Liangcai Zhao; Yanan Huang; Huanle Zhu; Zhihan Yan; Xuebao Wang; Xiaojie Wang; Guanghui Bai; Hongchang Gao
Journal:  Mol Brain       Date:  2014-11-26       Impact factor: 4.041

9.  Hemolytic disease of the fetus and newborn caused by anti-E.

Authors:  Adiyyatu Sa'idu Usman; Rapiaah Mustaffa; Noraida Ramli; Sirajo A Diggi
Journal:  Asian J Transfus Sci       Date:  2013-01

10.  Optimization of phenylhydrazine induced hyperbilirubinemia in experimental rabbit.

Authors:  Haq Nawaz; Muhammad Aslam Shad; Mohammad Saeed Iqbal
Journal:  Exp Anim       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.